Subramanian Sanjay 4
4 · Inozyme Pharma, Inc. · Filed Apr 20, 2022
Insider Transaction Report
Form 4
Subramanian Sanjay
SVP, CFO & Head of BD
Transactions
- Purchase
Common Stock
2022-04-19$3.69/sh+27,100$99,999→ 27,100 total
4 · Inozyme Pharma, Inc. · Filed Apr 20, 2022
Common Stock